Atlas Trials

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

Clinical trial NCT00367952 · COMPLETED

Trial details

NCT number
NCT00367952
Sponsor
Avexa
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infection
Start date
2006-08-01
Primary completion
2010-01-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.